Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
47
Number of overlapping holdings
21.0%
% of IBB's 261 holdings also in WDNA
56.0%
% of WDNA's 90 holdings also in IBB
Overlap by Weight
Sector Drift (IBB minus WDNA)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IBB |
Weight in WDNA |
Overlap | |
|---|---|---|---|---|
 |
NATERA INC | 2.0% | 3.7% | 2.0% |
|
GILEAD SCIENCES INC | 8.2% | 1.9% | 1.9% |
|
VERTEX PHARMACEUTICALS INC | 8.6% | 1.8% | 1.8% |
|
AMGEN INC | 8.4% | 1.7% | 1.7% |
|
ALNYLAM PHARMACEUTICALS INC | 3.6% | 1.6% | 1.6% |
Position Highlights (Non-Overlapping Exposures)
IBB Overweight Relative to WDNA
|
VERTEX PHARMACEUTICALS INC | 6.8% |
|
AMGEN INC | 6.7% |
|
GILEAD SCIENCES INC | 6.3% |
|
REGENERON PHARMACEUTICALS | 6.2% |
|
IQVIA HOLDINGS INC | 3.4% |
 |
METTLER-TOLEDO INTERNATIONAL | 2.6% |
|
WATERS CORP | 2.3% |
|
ALNYLAM PHARMACEUTICALS INC | 2.0% |
 |
ARGENX SE ADR | 1.8% |
|
BEIGENE LTD. SPONSORED ADR | 1.6% |
IBB Underweight Relative to WDNA
|
TWIST BIOSCIENCE CORP. | -3.0% |
 |
NOVOZYMES A/S-B SHARES | -2.9% |
|
ELI LILLY & CO | -2.7% |
|
VERICEL CORPORATION | -2.3% |
|
BLUEPRINT MEDICINES CORP. | -2.0% |
|
VERACYTE INC | -1.8% |
|
BRIDGEBIO PHARMA, INC. | -1.8% |
|
AGIOS PHARMACEUTICALS INC | -1.7% |
|
NATERA INC | -1.7% |
|
NOVARTIS AG | -1.7% |